The successful repair of DNA lesions is essential for cellular survival and the prevention of cancer^[@R1]^. Double-strand breaks (DSBs) are highly dangerous DNA lesions that are induced by various exogenous and endogenous agents, including ionising radiation and collapsed DNA replication forks. During late S and G2 phases of the cell cycle, high-fidelity repair of DSBs is promoted by homologous recombination (HR), in which the newly synthesised sister chromatid acts as a DNA repair template^[@R2]^. In contrast, during G1 and early S phases, the lack of a suitable homologous template means that DSBs must be repaired by the error-prone mechanism of non-homologous end joining (NHEJ)^[@R3]^. Optimal maintenance of genomic integrity thus depends on the successful execution of HR and NHEJ, and the appropriate choice of DSB repair pathway on the basis of cell cycle stage.

CtIP(RBBP8) was initially identified as a binding partner of the retinoblastoma protein (RB1)^[@R4]^, CtBP (C-terminal binding protein 1)^[@R5]^ and BRCA1^[@R6]^, and as a transcription factor with regulatory functions in G1/S cell-cycle progression and DNA damage-induced activation of the G2/M checkpoint^[@R7]-[@R10]^. Subsequent studies revealed its direct involvement in DNA DSB repair and the prevention of genomic instability^[@R11]^. It is now well established that CtIP plays key roles in DSB repair by HR and microhomology-mediated end joining (MMEJ)^[@R12]-[@R15]^. The DSB repair functions of CtIP are attributed to its role in promoting DNA-end resection, acting in functional and physical association with the MRE11-RAD50-NBS1 (MRN) complex^[@R11]^. CtIP recruitment to DSBs is required for effective formation of the RPA-coated 3′-ssDNA extensions that are a key intermediate in HR-mediated repair, and for activation of DNA-damage signalling by the protein kinase ATR^[@R11],[@R16]^. CtIP activity is regulated in a cell-cycle dependent manner, which affects the choice of DSB repair pathway: in S and G2 phases, cyclin-dependent kinase (CDK) phosphorylation of CtIP residues S327 (which is necessary for interaction with BRCA1) and T847 promotes HR^[@R12],[@R13],[@R17]^. In addition, CtIP is important for the limited DNA-end resection that promotes MMEJ during G1 phase^[@R12],[@R14],[@R15]^.

Extensive regions of amino acid conservation among vertebrate CtIP sequences are observed only at the N- and C-terminal ends of the molecule. Limited conservation of the CtIP C-terminal region extends to Sae2, the functional homolog of CtIP in *Saccharomyces cerevisiae*, which contains a CDK phosphorylation site that is functionally analogous to T847 of human CtIP^[@R13],[@R17]^. The N- and C-terminal regions of CtIP are independently capable of interacting with the MRN complex, and deletion of either region is sufficient to abrogate the function of CtIP in DNA-end resection and G2/M checkpoint activation^[@R11],[@R18]^. Primary sequence analysis of the conserved C-terminal region of CtIP has not provided clear insights into its mechanism of action, but it is likely to act as a recruitment module for macromolecular interactions with protein and nucleic acids that are regulated by phosphorylation. In contrast, considerable α-helical structure is predicted for the N-terminal region, suggesting that it might mediate key aspects of CtIP structure and function.

Biophysical studies in solution have provided evidence that amino acid residues 45 to 160 are responsible for CtIP dimerization via formation of an extended parallel coiled coil, interrupted in the middle by a putative zinc-binding motif C89-X-X-C92 (where X is any amino acid)^[@R19],[@R20]^. However, recent evidence suggests that dimer formation is insufficient to explain the essential role of the CtIP N-terminal region in DNA repair, as deletion of residues 20--45 or 22--45, which precede the dimerization domain, impairs DSB end-resection, HR, MMEJ and G2/M checkpoint activation^[@R18],[@R21]^. Here, we set out to elucidate the oligomeric state of human CtIP and its relevance to DNA repair. We demonstrate through biophysical and crystallographic analysis that the N-terminal region of CtIP adopts a tetrameric structure, mediated by antiparallel association of helical extensions protruding from the N-termini of two parallel coiled-coil dimers. Furthermore, we show that a point mutation that disrupts tetramer formation, while retaining CtIP dimerization, leads to failure of DNA-end resection and defective HR. We discuss potential functions for CtIP's 'dimer-of-dimers' assembly and why it is crucial for effective DNA repair.

RESULTS {#S1}
=======

The CtIP N-terminal region forms a tetramer {#S2}
-------------------------------------------

To gain insight into the structure of the CtIP N-terminal domain (CtIP-NTD), we expressed the region spanning CtIP residues 18 to 145 in *E. coli* and purified it to homogeneity ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Analysis by size-exclusion chromatography multi-angle light scattering (SEC-MALS) revealed that the CtIP-NTD forms a single tetrameric species corresponding to a molecular mass of 68.7 kDa ([Fig. 1b](#F1){ref-type="fig"}). Furthermore, we found that the tetrameric structure is almost entirely α-helical and shows high thermal stability ([Supplementary Fig. 2a, b](#SD1){ref-type="supplementary-material"}). Notably, we identified by microbeam proton-induced X-ray emission (microPIXE) analysis the presence of bound zinc with an estimated CtIP-NTD:Zn^2+^ ratio of 2:1 ([Supplementary Fig. 2g, h, i](#SD1){ref-type="supplementary-material"}), a conclusion supported by spectrophotometric assays based on 4-(2-pyridylazo)resorcinol (PAR)^[@R22]^, where zinc was detected at 40% of the molar protein concentration ([Fig. 1c](#F1){ref-type="fig"}). Furthermore, PAR analysis of a C89 and C92 double alanine mutant (CtIP-NTD-DM) detected only background quantities of zinc ([Fig. 1c](#F1){ref-type="fig"}), identifying C89 and C92 as ligands for the metal. The tetrameric structure and α-helical content of CtIP-NTD-DM were essentially the same as the non-mutated protein ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}), indicating that zinc binding is not required for tetramerization. These data thus established that the CtIP N-terminal domain adopts a helical tetrameric structure with two bound zinc ions.

Defining the CtIP tetramerization motif {#S3}
---------------------------------------

To identify the region mediating CtIP tetramerization within the CtIP-NTD, we truncated the N-terminal sequence that precedes the coiled-coil region ([Fig. 1a](#F1){ref-type="fig"}). SEC-MALS analysis of the ensuing region, comprising residues 52 to 145 (CtIP-cNTD), revealed a dimeric structure of 23.6 kDa ([Fig. 1d](#F1){ref-type="fig"}), indicating that residues N-terminal to the coiled-coil sequence are essential for tetramerization. We found that, like CtIP-NTD, CtIP-cNTD is almost entirely α-helical, shows high thermal stability ([Supplementary Fig. 2c, d](#SD1){ref-type="supplementary-material"}) and contains bound zinc, in agreement with a stoichiometry of one zinc atom per CtIP-cNTD dimer ([Fig. 1e](#F1){ref-type="fig"}). Importantly, while the double C89A C92A mutant protein no longer bound zinc ([Fig. 1e](#F1){ref-type="fig"}), it retained a dimeric structure, indicating that zinc is not required for dimerization. Nevertheless, the double C89A, C92A mutation caused an increase in the SEC elution volume of both CtIP-NTD and CtIP-cNTD, accompanied by reduced thermal stability ([Fig. 1b, d](#F1){ref-type="fig"} and [Supplementary Fig. 2b, d](#SD1){ref-type="supplementary-material"}), suggesting that the zinc-binding motif may act as a rigid strut holding the two flanking segments of predicted coiled-coil structure in an extended conformation.

To investigate further the nature of CtIP tetramerization, we analyzed the N-terminal sequence encoded by residues 18 to 52 (CtIP-nNTD). Remarkably, this short sequence of 35 amino acids was sufficient to support tetramerization, as demonstrated by SEC-MALS analysis of CtIP-nNTD, both as a free polypeptide and when fused to a maltose-binding protein (MBP) tag ([Fig. 1f](#F1){ref-type="fig"} and [Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}). We found that this tetrameric structure is α-helical in nature ([Supplementary Fig. 2e, f](#SD1){ref-type="supplementary-material"}) and, in keeping with our other data, does not contain bound zinc ([Fig. 1e](#F1){ref-type="fig"}). Collectively, these findings demonstrated that the CtIP N-terminal sequence comprising residues 18 to 52 is necessary and sufficient for CtIP tetramerization, mediated by head-to-head association between CtIP dimers.

Crystal structure of the CtIP tetramerization motif {#S4}
---------------------------------------------------

To define the molecular basis for CtIP tetramerization, we determined the X-ray crystal structure of human CtIP-nNTD at a resolution of 1.9 Å ([Table 1](#T1){ref-type="table"} and [Supplementary Fig. 1c](#SD1){ref-type="supplementary-material"}). Crystallographic analysis showed that the CtIP-nNTD adopts an entirely α-helical tetrameric structure, in which two CtIP dimers associate head-to-head through the interdigitating interaction of their splayed N-terminal tails ([Fig. 2](#F2){ref-type="fig"}). In this 'dimer-of-dimers' assembly, the antiparallel interactions between residues 18--31 in the CtIP-nNTD are responsible for tetramerization, whereas residues 32--52 form parallel dimeric coiled-coils ([Fig. 2](#F2){ref-type="fig"}). Each tetramerization helix is involved in two distinct sets of antiparallel interactions with the two N-terminal helices of the opposing CtIP dimer. In one set of interactions, the aromatic side chains of tryptophan residues at position 24 in each monomer pack against each other in a stacking interaction that is reinforced by reciprocal hydrogen bonding between the indole-ring nitrogen and the main-chain carbonyl group of the opposing tryptophan ([Fig. 3a](#F3){ref-type="fig"}); in the second set, leucine residues 23 and 27 interdigitate in canonical antiparallel coiled-coil fashion ([Fig. 3b](#F3){ref-type="fig"}). F20 contributes to both interfaces, by packing against the side chain of K28 ([Fig. 3a](#F3){ref-type="fig"}) and by adding one coiled-coil interaction with C30 of the antiparallel chain ([Fig. 3b](#F3){ref-type="fig"}). Thus, we conclude that the combination of antiparallel interactions provides a hydrophobic core that buries the side chains of F20 and L27 and likely drives tetramer formation.

The crystal structure further reveals that the C-terminal limit of the CtIP tetrameric interface is defined by H31, which packs against F20 of the opposing antiparallel chain to provide the outermost hydrophobic interaction of the tetramer, as well as the first dimerization contact in the coiled coil ([Fig. 3c](#F3){ref-type="fig"}). A parallel coiled-coil extends from H31 to the end of CtIP-nNTD, with residues V35, L38, V42 and L45 occupying canonical heptad-repeat positions at the hydrophobic interface ([Fig. 3c](#F3){ref-type="fig"}). The heptad repeat continues in the CtIP sequence until the zinc-binding site defined by C89-X-X-C92 ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}), indicating that the coiled-coil of the CtIP-nNTD is likely to be continuous with the coiled-coil structure of the CtIP-cNTD dimer. Taken together, our crystallographic and biophysical data lead to a structural model in which the CtIP-NTD undergoes tetramerization through head-to-head 'dimer-of-dimers' association mediated by the short N-terminal CtIP-nNTD sequence.

L27E mutation blocks CtIP tetramerization {#S5}
-----------------------------------------

Having defined the structural basis of CtIP tetramerization, we sought to test its physiological importance. Thus, we designed a point mutation replacing buried L27 with glutamate (L27E), to reverse the chemical nature of the amino-acid side chain. The mutation aimed to disrupt tetramerization while preserving the dimeric structure of CtIP, by introducing a charged residue in the hydrophobic core of the CtIP tetramerization motif ([Fig. 4a](#F4){ref-type="fig"}). Importantly, SEC-MALS analysis confirmed that a CtIP-NTD protein bearing the L27E mutation can only form dimeric species, and thereby had an equivalent effect on preventing dimer-of-dimers formation to deletion of amino acids 20 to 27, which removes the majority of the tetramerization helix ([Fig. 4b](#F4){ref-type="fig"}).

While we had shown that the L27E mutation does not interfere with CtIP-NTD dimerization *in vitro*, we wanted to confirm that this is also the case for full-length CtIP *in vivo*. Thus, we stably transfected human U2OS cells with FLAG-tagged versions of full-length wild-type CtIP, the single-point mutant L27E and a truncated form of the protein lacking the entire N-terminal domain, Δ1-140 CtIP ([Fig. 4c](#F4){ref-type="fig"}, top panel). Green-fluorescent protein (GFP)-tagged wild-type CtIP was then transiently expressed in these cells and immunoprecipitated. As revealed by their co-immunoprecipitation, both wild type and L27E forms of FLAG-CtIP interacted with GFP-CtIP, whereas Δ1-140 CtIP did not ([Fig. 4c](#F4){ref-type="fig"}, bottom panel). Thus, the L27E mutation does not affect the ability of CtIP to dimerise in cells, in agreement with our biophysical data.

To assess the impact of the L27E mutation in cells, the FLAG-epitope tagged construct of either wild-type or L27E mutant full-length CtIP protein was transfected transiently into human HEK-293T cells. FLAG-CtIP proteins were purified under stringent conditions so as to maintain only specific interactions (see Methods) and then subjected to size-exclusion chromatography. The later chromatographic elution of L27E CtIP indicated a substantial reduction in size, to approximately half the apparent molecular weight of the native molecule ([Fig. 4d](#F4){ref-type="fig"}). These findings demonstrated that full-length FLAG-tagged CtIP exists in cells in an oligomeric state, and established that oligomerisation is disrupted by the L27E mutation, consistent with head-to-head tetramerization mediated by its N-terminal domain occurring *in vivo*.

CtIP tetramerization is required for HR and promotes MMEJ {#S6}
---------------------------------------------------------

To test whether the DNA repair function of CtIP was affected by the L27E mutation, we took advantage of the fact that we had stably transfected wild-type and mutated CtIP constructs in a U2OS cell line containing the Traffic Light Reporter (TLR) system^[@R23]^ integrated into its genome. This system consists of an expression cassette containing a truncated *eGFP* gene fused to an *mCherry* gene that is out-of-frame translationally, and hence not expressed ([Fig. 5a](#F5){ref-type="fig"}). Transfection of cells with the endonuclease I-SceI generates a DSB in the *eGFP* gene that, when repaired by gene conversion (a form of HR) of an exogenous *eGFP* template, results in the production of a functional *eGFP* gene and cells acquiring green fluorescence. Alternatively, if the DSB is repaired by accurate NHEJ, the cassette is restored and no fluorescence is detected. If, however, mutagenic DSB repair takes place that results in a +2 translational frameshift, the *mCherry* reading frame is restored, causing cells to fluoresce red ([Fig. 5a](#F5){ref-type="fig"} and [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). The TLR system therefore allows the simultaneous measurement of DSB repair in cells by either mutagenic end-joining (mutEJ) or HR via gene conversion^[@R23]^.

To assess the effect of CtIP depletion in the TLR system, we performed the assay in control cells not expressing any recombinant form of CtIP and which had been treated with a control small-interfering RNA (siRNA) or an siRNA targeting the CtIP coding sequence. While CtIP depletion dramatically reduced the ability of cells to perform gene conversion ([Fig. 5b](#F5){ref-type="fig"}, left panel), as described previously in other HR reporter systems^[@R11]^, it slightly increased the occurrence of mutEJ events ([Fig. 5b](#F5){ref-type="fig"}, right panel), an effect that can be explained by CtIP depletion causing an imbalance in the HR/NHEJ/mutEJ ratio^[@R23],[@R24]^. Next, we carried out TLR assays with the U2OS-TLR cells that we had engineered to stably express siRNA-resistant wild-type, L27E or Δ1-140 CtIP proteins (see 'FLAG' inputs in [Fig. 4c](#F4){ref-type="fig"} for expression levels of each recombinant protein), and which had then been treated with an siRNA to deplete endogenous CtIP. As shown in [Fig. 5c](#F5){ref-type="fig"}, whereas wild-type CtIP restored HR proficiency to cells depleted of endogenous CtIP protein, both L27E and Δ1--140 CtIP failed to do so, essentially behaving as null mutants. ([Supplementary Fig. 4i](#SD1){ref-type="supplementary-material"} shows that a similar trend was observed in regards to decreasing the rate of mutEJ). Taken together, these results indicate that dimerization, which can still take place in the L27E CtIP mutant, is not sufficient for CtIP function in gene conversion and support a model in which CtIP 'dimer-of-dimers' tetramerization is required for this HR pathway.

CtIP's function during DNA repair is not exclusively linked to HR, as cells depleted of CtIP also show defects in MMEJ^[@R12]-[@R15]^. MMEJ is an alternative end-joining pathway that requires limited resection of the DSB, and differs from the classical NHEJ pathway in that it is independent of the Ku heterodimer and DNA-PK. In MMEJ, CtIP-mediated limited resection is believed to unveil regions of micro-homology that are used to anneal and ligate the broken DNA ends^[@R25]^. We used a U2OS-based system ([Fig. 5d](#F5){ref-type="fig"}, left panel; ref. [@R21]) to assess the impact of CtIP depletion on MMEJ ([Fig. 5d](#F5){ref-type="fig"}, right panel). We then generated U2OS-MMEJ cell lines stably expressing siRNA-resistant FLAG-tagged versions of CtIP and performed rescue experiments on cells depleted of endogenous CtIP by siRNA treatment. As shown in [Figure 5e](#F5){ref-type="fig"}, and in agreement with previous reports^[@R18]^, wild-type CtIP largely complemented CtIP deficiency, while Δ1--140 CtIP behaved as a null mutant. Interestingly, two independent L27E CtIP clones ([Supplementary Fig. 5a](#SD1){ref-type="supplementary-material"}) partially rescued the MMEJ deficiency of CtIP-depleted cells ([Fig. 5e](#F5){ref-type="fig"}), raising the possibility that CtIP dimers could be functional to some degree in this DNA repair pathway.

CtIP tetramerization promotes DNA-end resection {#S7}
-----------------------------------------------

CtIP localisation to sites of DNA damage is crucial for its function during DNA repair^[@R18],[@R21]^. To test whether CtIP tetramerization is important for the accumulation of CtIP at damaged sites, laser micro-irradiation was performed on U2OS cells stably expressing wild-type or L27E GFP-CtIP ([Supplementary Fig. 5b](#SD1){ref-type="supplementary-material"}). Upon irradiation, CtIP is known to accumulate at DNA-damage sites only in S-G2 cells. Strikingly, the L27E GFP-CtIP mutant protein showed a pronounced defect in localising to sites of DNA damage when compared to wild type GFP-CtIP ([Fig. 6a](#F6){ref-type="fig"}). Similar effects were observed when cells were treated with other DNA-damaging agents such as hydroxyurea or mitomycin C ([Fig. 6b](#F6){ref-type="fig"} and [Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}; note in [Fig. 6b](#F6){ref-type="fig"} that the L27E mutation did not affect the amount of DNA damage induced by such agents, as assessed by induction of the S139-phosphorylated form of histone H2AX (γH2AX), a well-established marker of DNA damage^[@R26]^). It has been reported that the N-terminal part of CtIP, where the tetramerization motif resides, is important for the constitutive interaction of CtIP with the MRN complex^[@R18]^ and that the MRN complex is required for localisation of CtIP to DNA-damage sites^[@R16]^. However, the L27E GFP-CtIP mutant protein interacts with the components of the MRN complex similarly to wild-type GFP-CtIP ([Fig. 6c](#F6){ref-type="fig"}).

The inability of CtIP-depleted cells to perform HR is at least in part explained by a defect in DNA-end resection^[@R11]^. Resection of a DSB is believed to be essential for all forms of HR, and involves the 5′-to-3′ nucleolytic degradation of DNA ends to generate single-stranded DNA (ssDNA) that is then rapidly bound by the ssDNA-binding protein replication protein A (RPA). Subsequently, RPA is replaced by RAD51 to form the nucleoprotein filaments that are necessary for strand invasion and completion of gene conversion^[@R27]^. To test whether the HR defect we observed in cells expressing the L27E CtIP mutant reflected impaired resection, we performed a flow-cytometry assay to detect RPA retention on chromatin^[@R28]^. RPA is present at all cell-cycle stages but only becomes chromatin-bound during S phase and when ssDNA is exposed under specific circumstances, such as when a DSB is resected. When CtIP is depleted, chromatin-bound RPA can still be detected in S-phase cells, but there is a dramatic reduction in DNA-damage dependent RPA chromatinization^[@R28]^. The DNA topoisomerase I inhibitor camptothecin generates DSBs at DNA replication forks^[@R29]^ that can only be repaired by HR and are channelled into the end-resection pathway^[@R30]^. We found that, after camptothecin treatment, CtIP-depleted cells exhibited a dramatic reduction of RPA chromatinisation that was rescued by expression of wild-type CtIP ([Fig. 6d](#F6){ref-type="fig"}, compare bottom panels 1 and 2 showing an increase from 0.5 to 25% RPA-positive cells). Notably, however, neither L27E CtIP nor Δ1--140 CtIP rescued the resection defect, despite all cell populations containing similar levels of DNA damage as scored by γH2AX immunostaining ([Fig. 6d](#F6){ref-type="fig"} and [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Thus, the HR defect sustained by cells expressing L27E CtIP or Δ1--140 CtIP correlated with their inability to engage DSBs in DNA-end resection. Collectively, these results implied that CtIP dimers are not functional during DNA-end resection and that tetramerization is crucial for CtIP localisation at DNA-damage sites, resection and HR.

DISCUSSION {#S8}
==========

We have demonstrated that mutation of CtIP to prevent its tetrameric assembly abrogates CtIP function in DNA-end resection and HR. Our crystallographic analysis shows that CtIP tetramer formation depends on interlocking interactions between N-terminal ends of opposing coiled-coil dimers. Although the crystal structure includes only residues up to position 52, the parallel coiled-coil structure is likely to extend to the whole CtIP N-terminal region up to residue 145, with the only interruption caused by the zinc-binding motif centred on C89 and C92. While the role of zinc coordination by CtIP is unclear (a C89A, C92A CtIP mutant is proficient in DNA-end resection, our unpublished results), our data suggest that it contributes to the conformational rigidity of the coiled-coil region.

Importantly, our analyses indicate that full-length CtIP undergoes multimeric assembly in cells, in a manner consistent with tetramerization through head-to-head assembly of CtIP dimers. Indeed, we find that the apparent molecular weight of full-length CtIP expressed in cells is reduced by approximately half upon introduction of the single-point mutation L27E, which we established biochemically to block tetrameric assembly while preserving dimerization of the CtIP N-terminal domain. As the L27E mutation behaves as a null CtIP mutant in DNA-end resection and HR, this leads us to conclude that the 'dimer-of-dimers' tetramer represents the functional oligomeric state of CtIP in these processes.

In agreement with our findings, previous biochemical studies identified a dimeric structure for CtIP residues 45 to 160^[@R19],[@R20]^. It was further reported that sedimentation equilibrium data of a CtIP protein spanning residues 22 to 160 could not be interpreted as a single species due to non-specific aggregation of the sample^[@R19]^. We note that this construct, while including the majority of residues involved in tetramerization, omits F20. Importantly, we have found that mutating F20 to glutamate leads to a mixed population of CtIP-NTD dimers and tetramers ([Supplementary Fig. 3b](#SD1){ref-type="supplementary-material"}), demonstrating that F20 is required for stable tetrameric assembly. In previous studies, deletions of CtIP residues 20--45, 22--45 or the combined mutations L27P, K28A, E29A, E34A were also found to block CtIP function in DNA-end resection and HR^[@R18],[@R21]^. On the basis of our *in vitro* and *in vivo* data, it is now apparent that the effects of such mutations can be explained by disruption of CtIP tetramerization.

Why is the L27E mutant protein unable to fulfill CtIP's roles in DNA-end resection and repair? It has been recently reported that CtIP possesses endonuclease activity^[@R31],[@R32]^. However, CtIP's function as an endonuclease seems to be dispensable for DNA-end resection and, importantly, is not affected by the deletion of the entire N-terminal region of CtIP^[@R32]^. Thus, the functional effects we have observed when abrogating CtIP tetramerization cannot reflect a possible negative impact on CtIP's putative nuclease activity. Perhaps surprisingly, we found that although L27E CtIP remains capable of interacting with the MRN complex, its accumulation at damage sites is impaired. This observation highlights the importance of CtIP's tetramerization state for its effective accrual at DNA-damage sites, although the precise nature of the underlying molecular mechanism remains unclear. In this regard, we note that CtIP function in DNA repair is intimately associated with that of the MRN complex. A well-established feature of the MRN complex is its ability to undergo long-range self-association mediated by a 'zinc hook' in the centre of a 600Å coiled-coil insertion in its RAD50 subunit^[@R33]^. These long-range interactions are thought to enable the complex to engage simultaneously multiple DNA molecules, a function that appears essential for effective HR repair. The molecular model of CtIP emerging from our data presents intriguing similarities to the functional architecture of the MRN complex. Given that the CtIP tetrameric structure spans 80 Å and each coiled-coil dimer contains up to eleven heptad repeats, a linear organisation of the CtIP N-terminal domain may reach up to \~300 Å in length ([Fig. 7](#F7){ref-type="fig"}). Thus, a CtIP tetramer might be able to position its C-terminal domains simultaneously onto distinct DNA molecules, where they would cooperate with the MRN complex and other factors to promote repair. In agreement with this model, we have found that a region of CtIP spanning residues 769 to 897 (C-terminal end of the protein) possesses DNA-binding ability ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}).

Finally, we note that Sae2, the functional orthologue of CtIP in *S. cerevisiae*^[@R34],[@R35]^, has also been shown to assemble into multimers^[@R36]^, and it was recently reported that post-translational modifications of Sae2 regulate its oligomeric state and function^[@R37]^. Although Sae2 is considerably smaller than CtIP, its N-terminal region is predicted to be helical, suggesting that Sae2 might also adopt a tetrameric structure. This therefore raises the prospect that similar regulatory mechanisms could act to switch CtIP between dimeric and tetrameric states and thereby control CtIP function in human cells. In this respect, we note that, while we have demonstrated that the 'dimer-of-dimers' tetrameric assembly is essential for end resection and HR, the results of the MMEJ assay suggest that CtIP dimers could function in other cellular processes, such as alternative modes of DNA repair or in gene transcription.

ONLINE METHODS {#S9}
==============

Recombinant protein expression and purification {#S10}
-----------------------------------------------

Sequences corresponding to human CtIP residues 1--145, 18--145, 18--52, 52--145 and 769--897, including point mutants L27E, F20E, double mutant C89A,C92A and Δ20-27, were cloned into pMAT11 vectors^[@R38]^ for expression as N-terminal His~6~-MBP fusion proteins. Constructs were expressed in BL21(DE3)Rosetta2 cells (Novagen®), in 2xYT media, induced with 0.5 mM IPTG for 16 hours at 20°C. Fusion proteins were purified from clarified lysate through consecutive Ni-NTA (Qiagen) and amylose (NEB) affinity chromatography. Affinity tags were removed by cleavage with TEV protease (Invitrogen) and capture on to Ni-NTA resin. Further purification was achieved through ion-exchange chromatography (Resource S for CtIP-nNTD, Resource Q for all other samples: GE Healthcare) and size-exclusion chromatography (HiLoad™ 16/60 Superdex 200: GE Healthcare) in 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM DTT. Protein samples were concentrated to 10 mg/ml using Amicon Ultra® 10,000 MWCO centrifugal filter units (Millipore), and were stored at −80°C following flash-freezing in liquid nitrogen.

Circular dichroism (CD) spectroscopy {#S11}
------------------------------------

Far-UV CD spectroscopy data were collected on an Aviv 410 spectropolarimeter (Biophysics facility, Department of Biochemistry, University of Cambridge). CtIP samples were analysed at 0.15 mg/ml, in 10mM Na~2~HPO~4~/NaH~2~PO~4~ pH 7.5, using a 1 mm path-length quartz cuvette (Hellma). CD spectra were recorded at 0.5 nm intervals between 260 and 185 nm (with 1 nm slit width and 1 s averaging time), at 5°C. Mean residue ellipticity (\[θ\]) was calculated from smoothed corrected raw data averaged across three recordings, and deconvolution was performed using the CDSSTR algorithm of the Dichroweb server (<http://dichroweb.cryst.bbk.ac.uk>)^[@R39],[@R40]^. CD thermal denaturation data were recorded at 222 nm, at 1°C intervals between 5 and 95°C (1°C/minute ramping rate, with 30 s incubation time). Raw data were converted to mean residue ellipticity (\[θ~222~\]).

Size-exclusion chromatography multi-angle light scattering (SEC-MALS) {#S12}
---------------------------------------------------------------------

The absolute molecular masses of recombinant CtIP protein samples were determined by size-exclusion chromatography multi-angle light scattering (SEC-MALS). 100 μl protein samples (at approximately 2 mg/ml) were loaded onto a Superdex™ 200 10/300 GL size exclusion chromatography column (GE Healthcare) in 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM DTT, at 0.5 ml/min using an ÄKTA™ Purifier (GE Healthcare). The column output was fed into a DAWN® HELEOS™ II MALS detector (Wyatt Technology), followed by an Optilab® T-rEX™ differential refractometer (Wyatt Technology). Light scattering and differential refractive index data were collected and analysed using ASTRA® 6 software (Wyatt Technology). Molecular masses and estimated errors were calculated across individual eluted peaks by extrapolation from Zimm plots using a dn/dc value of 0.1850 ml/g. SEC-MALS data are presented with light scattering (LS) and differential refractive index (dRI) plotted alongside fitted molecular masses (*M*~r~).

Spectrophotometric analysis of zinc content {#S13}
-------------------------------------------

A method for the spectrophotometric determination of zinc content was adapted from the published protocol^[@R22]^. CtIP recombinant protein samples at 0.5--0.1 mg/ml were digested with 0.6 μg/μl proteinase K (NEB) at 60°C for 1 hour. For each digested protein sample, in addition to standard solutions containing 0--100 μM zinc acetate, 10 μl of supernatant was added to 80 μl of 50 μM 4-(2-pyridylazo)-resorcinol (PAR) in 20 mM Tris pH 8.0, 300 mM NaCl, incubated for 5 minutes at room temperature, and UV absorbance spectra recorded between 600 and 300 nm (Varian Cary 50 spectrophotometer). Zinc concentrations were estimated by comparison of A~492nm~/(A~414nm~+A~492nm~) with lines of best fit obtained from analysis of 0--100 μM zinc acetate solutions. Protein concentrations were determined by UV spectrophotometry, with extinction coefficients and molecular weights calculated by ProtParam (<http://web.expasy.org/protparam/>).

Protein crystallisation and X-ray structure solution {#S14}
----------------------------------------------------

Protein crystals were obtained through hanging-drop vapour diffusion in which CtIP-nNTD at 4.7 mg/ml was mixed with equal volumes of reservoir solution (200 mM lithium sulphate, 100 mM sodium acetate pH 3.6, 32% (v/v) PEG 400) and equilibrated for 7--10 days. Suitable crystals were incubated in cryoprotectant (20 mM Tris pH 8.0, 150 mM sodium chloride, 200 mM lithium sulphate, 100 mM sodium acetate pH 3.6, 32% (v/v) PEG 400, 20% (v/v) glycerol) and frozen in liquid nitrogen. X-ray diffraction data were collected at 1.03970 Å wavelength as 1000 contiguous frames with 0.2 second exposure and 0.2 degrees of oscillation on a Pilatus 6M detector at beamline PROXIMA1 of the Soleil synchrotron in Paris, France. The data were indexed, integrated and scaled in XDS^[@R41]^, and merged using Aimless (CCP4 software package)^[@R42]^. The data could be indexed equally well in a monoclinic or orthorhombic lattice, and the crystal was initially assigned to orthorhombic space group P2~1~2~1~2~1~, with cell dimensions: a=36 Å, b=38 Å, c=98 Å and four predicted CtIP molecules in the asymmetric unit. The structure was solved with the molecular replacement method in Phaser^[@R43]^, using as search model a homology-model helical template spanning amino acids 18-52 of human CtIP, built by fold-recognition server PHYRE^[@R44]^. Phaser placed four copies of the helical template, arranged as an antiparallel dimer of two dimeric parallel coiled-coils. The tetrameric assembly was refined to 2.1 Å resolution with Phenix^[@R45]^ and Buster^[@R46]^, using Coot^[@R47]^ for manual model building. Reanalysis of the data processing during refinement highlighted the fact that the merging statistics were better in the case of monoclinic symmetry (P2~1~2~1~2~1~: R~merge~=0.180, R~meas~=0.195, R~pim~=0.073; P2~1~: R~merge~=0.056, R~meas~=0.065; R~pim~=0.034), and therefore refinement was continued in space group P2~1~, with two copies of the tetramer in the asymmetric unit. The final crystallographic model was refined to R and R~free~ values of 0.237 and 0.251 respectively, at a resolution of 1.9 Å, with all residues of the asymmetric unit in the favoured region of the Ramachandran plot.

Cell lines, culture conditions, drugs and transfections {#S15}
-------------------------------------------------------

Human U2OS and HEK-293T cells were grown in DMEM supplemented with 10% FBS, penicillin, streptomycin and glutamine. U2OS-TLR cells were selected in the presence of 2 μg/ml puromycin. U2OS-TLR cells stably transfected with FLAG-tagged versions of CtIP were grown in the presence of 0.5 μg/ml puromycin and 0.5 mg/ml geneticin. U2OS-MMEJ cells were described previously^[@R21]^. U2OS-MMEJ cells stably transfected with FLAG-tagged versions of CtIP were grown in the presence of 150 μg/ml hygromycin and 0.25 mg/ml geneticin. U2OS cells stably transfected with GFP-tagged versions of CtIP were grown in the presence of 0.5 mg/ml geneticin. Camptothecin, hydroxyurea and mytomycin C were from Sigma. Plasmid transfections were performed with Fugene HD (Promega) following manufacturer's conditions. siRNA transfections were performed with Lipofectamine RNAiMax (Life Technologies) using manufacturer's conditions.

Plasmids, siRNAs and antibodies {#S16}
-------------------------------

3×FLAG-CtIP vector was generated by replacing *eGFP* of GFP-CtIP^[@R11]^ with the 3×FLAG linker at the NheI and SalI sites. L27E was introduced in 3×FLAG-CtIP or GFP-CtIP by site-directed mutagenesis with Pfu Polymerase AD (Agilent Technologies). Δ1-140 3×FLAG-CtIP was generated by PCR with the 3×FLAG-CtIP plasmid as template. Antibodies for western blotting were: anti-FLAG M2 (Sigma F3165, 1:1000 dilution), anti-GFP 7.1/13.1 (Roche 11814460001, 1:1000), anti-RAD50 13B3 (Abcam ab89, 1:1000; see manufacturer's web page for validation details), anti-MRE11 (Abcam ab33125, 1:10000; see manufacturer's web page for validation details), anti-NBS1 1D7 (Abcam ab7860, 1:1000; see manufacturer's web page for validation details). siRNA sequences: Control siRNA (Luciferase 5′-CGUACGCGGAAUACUUCGA-3′), CtIP siRNA (5′-GCUAAAACAGGAACGAAUC-3′). All CtIP constructs are siRNA-resistant^[@R11]^.

Gel filtration {#S17}
--------------

Nuclear extracts from HEK-293T cells transiently transfected with plasmids expressing wild type or L27E versions of FLAG-CtIP were prepared as described previously^[@R48]^. NaCl concentration in extracts was adjusted to 300 mM and FLAG-tagged proteins were isolated by EZview Red anti-FLAG M2 Affinity gel (Sigma). Anti-FLAG beads were washed three times with lysis buffer containing 300 mM NaCl. Following elution with 3×FLAG peptide (Sigma) proteins were fractionated on a Superdex 75 HR 10/30 column (GE Healthcare). Relative molecular weights of the FLAG-CtIP protein complexes were calculated based on the elution profiles of the calibration standards (GE Healthcare), which were as follows: thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa), ovalbumin (44 kDa).

Immunoprecipitations (IPs) {#S18}
--------------------------

For CtIP dimer analyses, U2OS-TLR cells expressing versions of 3×FLAG-CtIP were transfected with a wild-type form of GFP-CtIP. 48 h after transfection, cells were scraped off 15 cm plates, pelleted and resuspended in 0.5 ml of lysis buffer (20 mM Tris-HCl pH 7.5, 40 mM NaCl, 2 mM MgCl~2~, 10% glycerol, 0.5% NP-40, EDTA-free protease inhibitors (Roche), 10 mM N-ethylmaleimide (Sigma-Aldrich), phosphatase inhibitor cocktail (42 μg/ml NaF, 0.22 mg/ml beta-glycerophosphate, 37 μg/ml Na~3~VO~4~, 2.2 mg/ml sodium pyrophosphate) containing 100 U of benzonase (Merck). After a 5 min incubation at room temperature, 50 μl of 5 M NaCl were added to the mix and tubes were left on ice for 15 min. Extracts were pelleted at 15 000 rpm at 4 °C for 45 min. Supernatants were recovered and diluted with 0.5 ml of lysis buffer with no benzonase. 1 mg of protein extract and 10 μl of GFP-Trap (ChromoTek) bead slurry were used per IP. IPs were incubated with rotation for 1.5 h at 4 °C. Beads were washed 5× with lysis buffer, changing tubes after the first wash. Immunoprecipitated proteins were eluted from the beads using 1× Lämmli buffer and boiling for 5 min. Samples were run in a 6% SDS-PAGE gel. For co-immunoprecipitations with known interactors, HEK-293T cells were transiently transfected with wild type or L27E GFP-CtIP, or the plasmid backbone expressing GFP only as a control. The rest was performed as described above. Samples were analysed in a 6-18% SDS-PAGE gel.

Generation of U2OS-TLR cells {#S19}
----------------------------

Viral particles containing pCVL Traffic Light Reporter 1.1 (Sce target) Ef1a Puro^[@R23]^ were generated by transfection of HEK-293T cells together with pMD2.G and psPAX2 (Addgene). Media containing the viral particles were collected 48 h after transfection, filtered and used to replace the medium of U2OS cells seeded the previous day. 48 h after media exchange, 2 μg/ml puromycin was added to select for integration events. Several clones were picked 10-15 days after starting selection and tested by transfection of pRRL sEF1a HA.NLS.Sce(opt).T2A.IFP (I-SceI nuclease plasmid) and pRRL SFFV d20GFP.T2A.mTagBFP Donor^[@R23]^. One of the clones displaying no background mCherry fluorescence in non-transfected cells and non-coincidental eGFP and mCherry fluorescence in cells transfected with both IFP-nuclease and BFP-Donor (indicative of a single integration of the TLR cassette) was selected for further experimentation.

TLR assay {#S20}
---------

U2OS-TLR cells were stably transfected with empty vector or forms of 3×FLAG-CtIP. Clones with similar expression levels of 3×FLAG-CtIP were selected ([Fig. 4c](#F4){ref-type="fig"}). 350 000 cells were seeded in 6-cm dishes and transfected with control siRNA (siLuciferase) or siRNA targeting CtIP. 6 h after transfection, plates were washed and cells were transfected with 2 μg of BFP-Donor and 3 μg of IFP-nuclease. 72 h after siRNA transfection, cells were collected by trypsinization, resuspended in 300 μl of 1× PBS + 1 mg/ml BSA and immediately analyzed in an LSR-Fortessa Cell Analyzer (BD Biosciences) ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}). Alternatively, cells were fixed for 20 min at room temperature in 2% paraformaldehyde in 1× PBS, washed, resuspended in 300 μl of 1× PBS + 1 mg/ml BSA and kept at 4 °C for posterior analysis.

Flow-cytometry analysis was performed by exciting BFP with a 405 nm laser and emissions collected via a 450/50 filter. IFP was excited with a 635 nm laser and emissions collected via a 670/30 filter. eGFP was excited with a 488 nm laser and emissions collected via a 530/30 filter. mCherry was excited with a 561 nm laser and emissions collected via a 610/20 filter. For a representative example of the gating strategy, see [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}. Background signal was subtracted for each sample and the intensity of the BFP signal was used to normalise the percentages of eGFP-positive cells, as the efficiency of homologous recombination increases with increasing amounts of transfected BFP-Donor^[@R23]^. Data analysis was performed using FlowJo X (Tree Star).

MMEJ assay {#S21}
----------

U2OS-MMEJ cells^[@R21]^ were stably transfected with empty vector or forms of 3×FLAG-CtIP. Clones with similar expression levels of 3×FLAG-CtIP were selected ([Supplementary Fig. 5a](#SD1){ref-type="supplementary-material"}). 350 000 cells were seeded in 6-cm dishes and transfected with control siRNA (siLuciferase) or siRNA targeting CtIP. 6 h after transfection, plates were washed and cells were transfected with 3 μg of pCBASce, a vector that expresses I-SceI nuclease^[@R49]^. 72 h after siRNA transfection, cells were collected by trypsinization, resuspended in 300 μl of 1× PBS + 1 mg/ml BSA and immediately analyzed in an LSR-Fortessa Cell Analyzer (BD Biosciences). Flow cytometry analysis was performed by exciting eGFP with a 488 nm laser and emissions collected via a 530/30 filter. Data analysis was performed using FlowJo X (Tree Star).

Laser micro-irradiation and immunofluorescence {#S22}
----------------------------------------------

For generation of localized damage in cellular DNA by exposure to a UV-A laser beam^[@R50],[@R51]^, cells were plated on glass-bottomed dishes (Willco-Wells) and presensitized with 10 μM BrdU (Sigma-Aldrich) in phenol red-free medium (Invitrogen) for 24 h at 37°C. Laser micro-irradiation was performed by using a FluoView 1000 confocal microscope (Olympus) equipped with a 37°C heating stage (Ibidi) and a 405-nm laser diode (6 mW) focused through a 603 UPlanSApo/1.35 oil objective to yield a spot size of 0.5--1 mm. The time of cell exposure to the laser beam was \~250 msec (fast scanning mode). Laser settings (0.4-mW output, 50 scans) were chosen to generate a detectable damage response restricted to the laser path in a presensitization-dependent manner without noticeable cytotoxicity. Imaging was done on the same microscope by using the objective and software as described above.

30 min after irradiation, cells were washed three times with PBS followed by fixation with 2% paraformaldehyde (w/v) in PBS for 10 min. Following three washes with PBS, Cells were permeabilised in 0.5% Triton X-100 in PBS for 5 min. Following three washes with PBS, cells were co-stained with primary antibodies against γH2AX (Cell Signaling 2577, 1:500 dilution; see manufacturer's web page for validation details) and cyclin A H432 (Santa Cruz sc-751, 1:500; see manufacturer's web page for validation details) in 5% FBS in PBS for 1 h at RT. Following three washes with PBS, cells were stained with goat anti-rabbit Alexa Fluor 594 secondary antibody (Molecular Probes, 1:1000) in 5% FBS in PBS for 30 min at RT.

Quantification of GFP-CtIP accumulation in damaged cells {#S23}
--------------------------------------------------------

U2OS cells stably expressing wild-type or L27E mutant GFP-CtIP were left untreated or treated for 24 h with 1 mM hydroxyurea or 120 ng/ml mytomycin C. After treatment cells were trypsinised, collected and resuspended in extraction buffer (25 mM HEPES pH 7.4, 50mM NaCl, 1 mM EDTA, 3 mM MgCl~2~, 300 mM sucrose, 0.5% Triton X-100, protease inhibitors) for 5 min on ice. After washing with 1×PBS + 1 mg/ml BSA (PBS-B), cells were fixed for 20 min at room temperature in 2% paraformaldehyde in 1×PBS. After washing with PBS-B, cells were incubated with antibodies against γH2AX (Cell Signalling 2577, 1:200). Antibody detection was by incubating cells with goat anti-rabbit Alexa Fluor 594 (Molecular probes, 1:1000). DNA was stained with 4′,6-diamidino-2-phenylindole (DAPI). Samples were analyzed in an LSR-Fortessa Cell Analyzer (BD Biosciences). Data analysis was performed using FlowJo X (Tree Star).

DNA-end resection assay {#S24}
-----------------------

Sample preparation was as described previously^[@R28]^. Briefly, U2OS-TLR cells expressing forms of 3×FLAG-CtIP were transfected with control siRNA (siLuciferase) or siRNA targeting CtIP. 48 h after transfection, cells were left untreated or treated with 1 μM camptothecin for 1 h. After permeabilization and fixation, cells were incubated with antibodies against an RPA subunit (RPA2 9H8; Abcam ab2175 1:500 dilution; see manufacturer's web page for validation details) and γH2AX (Cell Signalling 2577, 1:200). Antibody detection was by incubating cells with goat anti-mouse Alexa Fluor 488 (Molecular probes, 1:1000) and goat anti-rabbit Alexa Fluor 594 (Molecular probes, 1:1000). DNA was stained with 4′,6-diamidino-2-phenylindole (DAPI). Samples were analyzed in an LSR-Fortessa Cell Analyzer (BD Biosciences). Data analysis was performed using FlowJo X (Tree Star).

Electrophoretic mobility shift assay {#S25}
------------------------------------

CtIP constructs for the NTD and CTD were incubated with 1μM fluorescein-labelled 200bp double-stranded DNA at concentrations: 0, 0.5, 1.0, 2.0, 5.0 and 10μM in 20 mM Tris pH 8.0, 150mM NaCl for 60 minutes in darkness at room temperature. To the 10μl reaction volume, 2μl of gel loading buffer comprising of 250mM Tris pH 8.0, 40% glycerol and bromophenol blue was added and samples were analysed by electrophoresis on a 1.5% (wt/vol) agarose gel (Ultra Pure Invitrogen) in 0.5xTB buffer at 25V for 2.5h at 4°C. DNA was visualised in a Gel Doc-It visualisation system using UV light.
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======================
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**Accession codes.** Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4D2H.

![CtIP-NTD (amino acids 18--145) exists as a tetramer in solution.\
(**a**) Schematic diagram of the human CtIP sequence. Based on bioinformatics analysis, the CtIP N-terminal domain (NTD) can be divided in a helical (α) N-terminal region (CtIP-nNTD) and a C-terminal region (CtIP-cNTD) in which a central C89-X-X-C92 motif is flanked by predicted coiled coils (CC). The conserved C-terminal domain (CTD) and the two CDK phosphorylation sites are also depicted. (**b**) Size-exclusion chromatography multi-angle light scattering (SEC-MALS) analysis of wild-type and C89A, C92A double mutant (DM) recombinant CtIP-NTD. The light scattering (LS) as relative Raleigh ratio and the differential Reflective Index (dRI) are drawn as solid and dashed lines, respectively. The values for the fitted molecular masses (*M*~r~) of CtIP-NTD and CtIP-NTD-DM are shown as diamond shapes across the respective elution peaks. The predicted molecular masses of the monomeric species are shown in brackets above each elution peak. (**c**) Spectrophotometric determination of zinc content for CtIP-NTD (solid line) and CtIP-NTD-DM (dashed line) using metal chelator 4-(2-pyridylazo) resorcinol (PAR), with zinc standards shown in grey. (**d**) SEC-MALS analysis of CtIP-cNTD and CtIP-cNTD-DM. (**e**) PAR analysis for CtIP-cNTD (solid line), CtIP-cNTD-DM (dashed line) and CtIP-nNTD (dotted line), respectively. (**f**) SEC-MALS analysis of CtIP-nNTD.](emss-61179-f0001){#F1}

![Crystal structure of the tetramerization domain of human CtIP (CtIP-nNTD; amino acids 18--52).\
The CtIP-nNTD tetramer is formed through the head-to-head association between two CtIP dimers, drawn as ribbons and colored orange and purple. The N- and C-termini of each CtIP molecule are labeled. The central tetrameric assembly consists of interlocking, antiparallel interactions between the two pairs of N-terminal helices comprising amino acids 18--31. The C-terminal amino acids 32--52 are part of the region responsible for CtIP dimerization via parallel coiled-coil interactions. Two views of the CtIP-nNTD structure are shown, related by 90° rotation around the long axis of the tetramer.](emss-61179-f0002){#F2}

![Details of the homotypic interactions responsible for tetrameric assembly (**a, b**) and dimerization (**c**) of CtIP.\
Each panel shows a ribbon drawing of the CtIP-nNTD (top) and side-chain details of CtIP interactions responsible for self-association (bottom). For clarity, only the two CtIP chains for which details of side-chain interactions are shown are colored (as in [Figure 2](#F2){ref-type="fig"}), whereas the other two chains are in light grey. (**a**) Antiparallel interactions in the tetramerization motif (residues 18--31) involve side-chain stacking of tryptophan residues at position 24 and reciprocal hydrogen bonding (depicted as yellow springs) between their indole ring nitrogens and main-chain carbonyl groups. The side chains of interacting residues F20 and K28 are also shown. (**b**) Coiled-coil contacts in the tetramerization motif involve residues F20, L23, L27 and C30 from adjacent pairs of antiparallel helices. (**c**) The coiled-coil dimer is formed between parallel C-terminal sequences (residues 31--52), with residues V35 and V42 at the 'a' position and residues H31, L38 and L45 at the 'd' position of the heptad repeat. Histidine residue 31 marks the transition point between the tetramerization motif and the coiled-coil dimer structure.](emss-61179-f0003){#F3}

![CtIP mutation L27E abrogates tetramer assembly while preserving dimerization.\
(**a**) Structure of the CtIP-nNTD, showing the position of L27 in the hydrophobic core of the tetramer. CtIP is drawn as ribbon, with the tetramerization region in red and the rest of the chain in yellow. The side chain of L27 is shown in green as stick drawing. (**b**) SEC-MALS analysis of L27E CtIP-NTD and Δ20-27 CtIP-NTD. The LS as relative Raleigh ratio, dRI, fitted and predicted *M*~r~ values are reported as in [Figure 1](#F1){ref-type="fig"}. (**c**) *Top panel:* diagram of the FLAG-tagged CtIP derivatives used in the immunoprecipitation (IP) experiments. The CtIP-NTD region is coloured as in panel **a**. *Bottom panel:* western blot showing co-immunoprecipitation of wild-type (WT) GFP-CtIP with the WT and L27E versions of FLAG-CtIP, but not with CtIP Δ1-140. Control IP was performed with cells that express WT FLAG-CtIP transfected with a GFP-expressing plasmid. (**d**) Western blot of the fractions from a gel-filtration experiment shows that FLAG-tagged wild-type (WT) CtIP (upper panel, peak at fraction 3) elutes earlier than the corresponding L27E mutant (lower panel, peak at fraction 7). Inputs are shown in the first lane. The elution volume of each fraction, the elution position for size markers ferritin (440 kDa) and aldolase (158 kDa) and the estimated elution position of WT FLAG-CtIP and L27E FLAG-CtIP are also shown. Uncropped images for all western blot data can be seen in [Supplementary Data Set 1](#SD2){ref-type="supplementary-material"}.](emss-61179-f0004){#F4}

![CtIP mutation L27E impairs HR and, to a lesser extent, MMEJ.\
(**a**) Schematic of the Traffic Light Reporter (TLR) system (adapted from ref. [@R23]; see also [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). (**b**) CtIP depletion reduces HR efficiency (left panel) and slightly increases the rate of mutagenic end-joining (right panel) in the TLR system. (**c**) Only expression of wild-type (WT) FLAG-tagged CtIP rescues the HR deficiency caused by endogenous CtIP depletion. All values are normalised to cells transfected with control siRNA. (**d**) *Left panel*: schematic of the MMEJ system (adapted from ref. [@R21]). *Right panel*: CtIP depletion impairs MMEJ. (**e**) L27E FLAG-CtIP is not completely defective in MMEJ. EV: empty vector. All quantifications are averages of n = 3 biological replicates (independent siRNA transfections). Error bars are ± SEM.](emss-61179-f0005){#F5}

![CtIP mutation L27E impairs CtIP accumulation at DNA-damage sites and DNA-end resection.\
(**a**) L27E GFP-CtIP shows defective accumulation at laser-induced DNA-damage sites. Samples were fixed 30 min after irradiation. Cells were stained with γH2AX (to detect damaged cells) and cyclin A (to identify cells in S and G2 phases of the cell cycle) antibodies. (**b**) L27E GFP-CtIP also shows defective accumulation in other DNA-damaging conditions. Cells were left untreated or treated for 24 h with 1 mM hydroxyurea (HU) or 120 ng/ml mytomycin C (MMC). Quantification of γH2AX-positive cells is shown as control for DNA damage (see also [Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}) (**c**) L27E GFP-CtIP interacts with the MRN complex. (**d**) Only expression of wild-type (WT) FLAG-tagged CtIP rescues the resection defect caused by endogenous CtIP depletion. *Left panel:* dot plots representing the intensity of the signal of RPA staining (*y* axis) against the DNA content (*x* axis). Quantification gates were established in untreated samples ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). *Right panel:* quantification of RPA-positive cells. All values are normalised to the percentage of γH2AX-positive cells and to cells transfected with control siRNA ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). EV: empty vector. All quantifications are averages of n = 3 biological replicates (independent siRNA transfections). Error bars are ± SEM. Uncropped images for all western blot data can be seen in [Supplementary Data Set 1](#SD2){ref-type="supplementary-material"}.](emss-61179-f0006){#F6}

![Model for the functional architecture of human CtIP.\
The central tetrameric assembly of the NTD holds CtIP dimers in a head-to-head orientation. The two ends of this central tetramer extend into coiled-coil structures that define the CtIP dimers. Each dimer comprises two coiled-coil regions flanking a central zinc-binding site, in which one zinc ion is co-ordinated by C89 and C92 of the two CtIP chains. The CtIP-NTD may span a total distance of up to 300 Å.](emss-61179-f0007){#F7}

###### Data collection and refinement statistics

                                                                                           CtIP-nNTD (amino acids 18--52)
  ---------------------------------------------------------------------------------------- --------------------------------
  **Data collection**                                                                      
  Space group                                                                              P2~1~
  Cell dimensions                                                                          
   *a*, *b*, *c* (Å)                                                                       35.97, 37.91, 97.79
   a, b, g (°)                                                                             90.00, 90.02, 90.00
  Resolution (Å)                                                                           28.98 - 1.90 (1.94 - 1.90)
  *R* ~merge~                                                                              0.063 (0.919)
  *R* ~meas~                                                                               0.074 (1.074)
  *R* ~pim~                                                                                0.038 (0.547)
  *I* / s*I*                                                                               10.2 (1.6)
  CC(1/2)                                                                                  0.998 (0.770)
  Completeness (%)                                                                         99.5 (99.5)
  Multiplicity                                                                             3.6 (3.6)
                                                                                           
  **Refinement**                                                                           
  Resolution (Å)                                                                           28.97 - 1.90
  No. reflections                                                                          20969
  *R*~xpct~^[a](#TFN1){ref-type="table-fn"}^/ *R*~free~^[b](#TFN2){ref-type="table-fn"}^   0.212/0.251
  No. atoms                                                                                2474
   Protein                                                                                 2267
   Ligand/ion                                                                              70
   Water                                                                                   137
  *B*-factors                                                                              49.2
   Protein                                                                                 47.4
   Ligand/ion                                                                              103.4
   Water                                                                                   52.5
  R.m.s. deviations                                                                        
   Bond lengths (Å)                                                                        0.012
   Bond angles (°)                                                                         1.34

Values in parentheses are for highest-resolution shell.

$R_{xpct} = \frac{\sum_{hkl} \mid \mid F_{obs} \mid - \mid F_{xpct} \mid \mid}{\sum_{hkl} \mid F_{obs} \mid}$, where F~obs~ and F~xpct~ are the observed structure-factor amplitude and the expectation of the model structure factor amplitude, respectively^[@R46]^.

R~free~ equals R~xpct~ of the test set (5% of the data that were excluded from refinement).
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